NDC 70860-211 – Fulvestrant

Fulvestrant 50 mg/mL · Injection, Solution · Intramuscular

Human Prescription Drug

Product NDC70860-211

Product details

Brand name
Fulvestrant
Generic name
Fulvestrant
Labeler
Athenex Pharmaceutical Division, LLC.
Dosage form
Injection, Solution
Route
Intramuscular
Marketing category
ANDA · ANDA211422
Marketed since
February 18, 2020
Marketing end
December 31, 2026
Pharmacologic class
Estrogen Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Fulvestrant →

Package NDC codes (1)

Package NDCDescriptionSince
70860-211-742 SYRINGE, GLASS in 1 CARTON (70860-211-74) / 5 mL in 1 SYRINGE, GLASS (70860-211-41)Feb 18, 2020

Other Fulvestrant products